Wolverine Trading
MDGL icon

Wolverine Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History

Wolverine Trading’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.32M Buy
7,500
+5,300
+241% +$1.98M ﹤0.01% 1736
2025
Q2 		$662K Sell
2,200
-2,800
-56% -$834K ﹤0.01% 2681
2025
Q1 		$1.64M Sell
5,000
-9,400
-65% -$3.09M ﹤0.01% 1787
2024
Q4 		$4.49M Buy
14,400
+2,200
+18% +$619K ﹤0.01% 1278
2024
Q3 		$2.59M Sell
12,200
-3,200
-21% -$819K ﹤0.01% 1504
2024
Q2 		$4.31M Sell
15,400
-10,200
-40% -$2.43M ﹤0.01% 1064
2024
Q1 		$6.84M Buy
25,600
+19,500
+320% +$4.59M 0.01% 829
2023
Q4 		$1.41M Sell
6,100
-1,400
-19% -$245K ﹤0.01% 1970
2023
Q3 		$1.1M Sell
7,500
-5,800
-44% -$1.09M ﹤0.01% 2057
2023
Q2 		$2.93M Buy
13,300
+4,200
+46% +$1.14M ﹤0.01% 1250
2023
Q1 		$2.14M Buy
+9,100
New +$2.48M ﹤0.01% 1329
2022
Q4 		– Sell
-9,300
Closed -$585K – 4617
2022
Q3 		$585K Sell
9,300
-1,800
-16% -$125K ﹤0.01% 2479
2022
Q2 		$799K Buy
+11,100
New +$816K ﹤0.01% 2115
2022
Q1 		– Sell
-8,400
Closed -$713K – 6027
2021
Q4 		$713K Sell
8,400
-200
-2% -$16.4K ﹤0.01% 3012
2021
Q3 		$688K Buy
+8,600
New +$743K ﹤0.01% 3502
2021
Q2 		– Sell
-3,700
Closed -$431K – 6417
2021
Q1 		$431K Sell
3,700
-400
-10% -$46.6K ﹤0.01% 3920
2020
Q4 		$456K Hold
4,100
– – ﹤0.01% 3280
2020
Q3 		$489K Buy
+4,100
New +$445K ﹤0.01% 2849

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Wolverine Trading's MDGL Position: Q3 2025 in Review

Wolverine Trading increased its Madrigal Pharmaceuticals (MDGL) stake by 420% in Q3 2025, buying an estimated $1.52M and bringing the position to 5,056 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2071.

Wolverine Trading first reported a position in MDGL in Q2 2016 and has held it in 18 quarters since. 352 funds tracked by Wall St. Rank hold MDGL as of Q3 2025.

  • Wolverine Trading held 5,056 shares of Madrigal Pharmaceuticals worth $2.24M as of Q3 2025.
  • Wolverine Trading bought 4,084 Madrigal Pharmaceuticals shares in Q3 2025, an estimated $1.52M.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2071 holding.
  • Wolverine Trading first reported a position in Madrigal Pharmaceuticals in Q2 2016 and has held it in 18 quarters since.
  • 352 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.